MVEC eLearning: Vaccine Errors: Prevention, management and open disclosure

MVEC are excited to launch the next of our eLearning packages. Our eLearning packages are designed to allow immunisation providers to consolidate and evaluate their technical skills. Targeted resources are available to assist with our eLearning and a certificate of completion will be made available upon completion of the corresponding eLearning quiz.

Vaccine Errors: Prevention, management and open disclosure has been designed to provide an overview of how to prevent errors of vaccine administration, the management of a vaccine error and to demonstrate the open disclosure process.

You can access Vaccine Errors: Prevention, management and open disclosure via our MVEC Education Portal or via the following link:

MVEC eLearning: Vaccine Errors: Prevention, management and open disclosure


Joint statement between RANZCOG and ATAGI about COVID-19 vaccination for pregnant women

The Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) and ATAGI have released a joint statement regarding COVID-19 vaccines and pregnant women.

It is recommended that pregnant women are routinely offered Comirnaty™ at any stage of pregnancy. This recommendation has been made based on the increased risk of severe outcomes for pregnant women and their unborn baby, should the woman develop COVID-19 disease

This advice reflects the findings of international data which has not identified any safety signals following the administration of mRNA COVID-19 vaccines to pregnant women. Further to this, antibodies have been detected in the cord blood and breastmilk of vaccinated women, suggesting the transfer of protection to the baby,

To read the statement in full please refer to the following link:

Joint statement between RANZCOG and ATAGI about COVID-19 vaccination for pregnant women

 


RACGP - Australian authorities update side effect advice on AstraZeneca vaccine

Following the recent joint statement from ATAGI and the Thrombosis and Haemostasis Society of Australia and New Zealand (THANZ), RACGP confirms that almost anyone over the age of 50 can safely receive the AstraZeneca vaccine. The statement also clarifies that the rare blood clotting condition that has been linked with the use of AstraZeneca’s vaccine in some groups – Thrombosis with Thrombocytopenia Syndrome (TTS) – can now be treated effectively.

The latest release also confirms that the risk of TTS is not likely to be increased in people with the following conditions (and that over-50s in these groups can still get vaccinated with AstraZeneca):

  • History of blood clots in typical sites
  • Increased clotting tendency that is not immune mediated
  • Family history of blood clots
  • History of ischaemic heart disease or stroke
  • Current or past thrombocytopenia (low platelet count)
  • Those receiving anticoagulation therapy

Furthermore, the ATAGI/THANZ statement also reports that UK data suggest the risk of TTS is much lower following a second dose, with only 15 cases reported to date out of nine million administered, translating to an estimated rate of 1.7 cases per million doses.

Please refer to the article and statement in full in the following link:
RACGP - Australian authorities update side effect advice on AstraZeneca vaccine


Updated immunisation reference pages: TTS, G6PD and COVID-19 vaccines and allergy

We have recently updated some of our immunisation reference pages to include the latest information and recommendations regarding COVID-19 vaccines. To view these pages please follow the links below:

MVEC: Thrombosis with thrombocytopenia syndrome (TTS)
MVEC: G6PD deficiency and vaccines
MVEC: COVID-19 vaccines and allergy


BBC: Covid Vaccines: No, your jab isn't magnetic

Videos of people sticking magnets to where they claim they've had the Covid vaccine have racked up millions of views on social media platforms like TikTok and Instagram.

Some people say there must be something magnetic in the vaccines and others have gone further to say it’s proof of a microchip - a theory which just isn’t true.

BBC Reality Check's Jack Goodman debunks the so-called #magnetchallenge.

To read more, follow the link below:

BBC: Covid Vaccines: No, your jab isn't magnetic


Raising Children Network - new COVID-19 vaccination: pregnancy and breastfeeding resource

MVEC have partnered with the Raising Children Network to develop a new resource focused on providing COVID-19 vaccine recommendations for women who are pregnant, breastfeeding or planning pregnancy.

To view this article follow the link below:

COVID-19 vaccination: pregnancy and breastfeeding

Further information on vaccines for pregnant and breastfeeding women can be found via our immunisation reference pages below:

MVEC: Maternal vaccination during pregnancy

MVEC: Breastfeeding and immunisations

 

 


BBC News: Covid: Pfizer and AstraZeneca jabs work against Indian variant - study

A study conducted by Public Health England (PHE) has shown that either of the Pfizer or AstraZeneca COVID-19 vaccine brands are highly effective against the COVID-19 Indian strain. Two weeks after the administration of dose 2, the Pfizer vaccine was found to be 88% effective at stopping symptomatic disease and the AstraZeneca vaccine was 60% effective.

The effectiveness of only 1 dose of either brand was reduced to 33%, highlighting the importance of administering both doses.

To read more, follow the link below:

BBC News: Covid: Pfizer and AstraZeneca jabs work against Indian variant - study


nature: COVID vaccines and kids- five questions as trials begin

With a number of COVID-19 vaccine trials now focusing on paediatric populations across various age groups, specific factors need to be considered.

The following article explores issues such as the consent process for paediatric involvment, the robust immune responses of children, and monitoring for signs of exacerbated immune responses and multisystem inflammatory syndrome in children.

Whilst severe COVID-19 disease in children is rare, the immunisation of children against COVID-19 disease will play an important role in achieving herd immunity.

To read more, please read the article below:
nature: COVID vaccines and kids: five questions as trials begin


New resource: Australia's COVID-19 vaccine rollout

For easily accessible information relating to the COVID-19 vaccine rollout, the Australian Government Department of Health have created a new resource page. This page will be updated daily and describes the number of vaccine doses administered via the various providers, makes comparisons to international COVID-19 vaccine programs, and provides other sources of useful data.

To view this page please refer to the link below:

Australian Government Department of Health: Australia's COVID-19 vaccine rollout


A recording of the 26th April CVU mini is now available

Thank you to all who attended our recent CVU miniseries event COVID-19 vaccine: reporting and management in Victoria on 26th April 2021.

This interactive webinar looked at the latest vaccine safety questions around COVID-19 vaccines, guidelines for referring patients for evaluation prior to vaccination (VicSIS), and reporting safety events related to COVID-19 vaccines.

A recording of this event is now available via our education portal.

To access this recording please follow the link below:

CVU mini - 26th April 2021